EIA
LMAT icon

Emerald Investment Advisers’s LeMaitre Vascular LMAT Stock Holding History

Emerald Investment Advisers’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49M Buy
36,366
+1,398
+4% +$143K 0.23% 142
2026
Q1 		$3.82M Buy
+34,968
New +$3.33M 0.34% 102

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Emerald Investment Advisers's LMAT Position: Q2 2026 in Review

Emerald Investment Advisers increased its LeMaitre Vascular (LMAT) stake by 4% in Q2 2026, buying an estimated $143K and bringing the position to 36,366 shares worth $3.49M. The position accounts for 0.23% of the portfolio, ranked #142.

Emerald Investment Advisers first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.82M in Q1 2026. 325 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Emerald Investment Advisers held 36,366 shares of LeMaitre Vascular worth $3.49M as of Q2 2026.
  • Emerald Investment Advisers bought 1,398 LeMaitre Vascular shares in Q2 2026, an estimated $143K.
  • LeMaitre Vascular made up 0.23% of Emerald Investment Advisers's portfolio in Q2 2026, its #142 holding.
  • Emerald Investment Advisers first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • Emerald Investment Advisers's LeMaitre Vascular position peaked at $3.82M in Q1 2026.
  • 325 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Emerald Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.